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Summary
Familial juvenile polyposis (FJP) is a hamartomatous
polyposis syndrome in which affected family members
develop upper and lower gastrointestinal juvenile polyps
and are at increased risk for gastrointestinal cancer. A
genetic locus for FJP has not yet been identified by link-
age; therefore, the objective of this study was to perform
a focused genome screen in a large family segregating
FJP. No evidence for linkage was found with markers
nearMSH2,MLH1,MCC, APC,HMPS,CDKN2A, JP1,
PTEN, KRAS2, TP53, or LKB1. Linkage to FJP was
established with several markers from chromosome
18q21.1. The maximum LOD score was 5.00, with
marker D18S1099 (recombination fraction of .001).
Analysis of critical recombinants places the FJP gene in
an 11.9-cM interval bounded by D18S1118 and
D18S487, a region that also contains the tumor-sup-
pressor genes DCC and DPC4. These data demonstrate
localization of a gene for FJP to chromosome 18q21.1
by linkage, and they raise the possibility that eitherDCC
or DPC4 could be responsible for FJP.
Introduction
Familial juvenile polyposis (FJP) is an autosomal dom-
inant condition characterized bymultiple juvenile polyps
of the gastrointestinal (GI) tract. Kindreds have been
described in which there is involvement of the colon only
(juvenile polyposis coli, MIM 174900) (Veale et al.
1966; Grotsky et al. 1982; Rozen and Baratz 1982), the
upper GI tract (Watanabe et al. 1979), and both upper
and lower GI tracts (generalized polyposis) (Sachatello
et al. 1970; Stemper et al. 1975; Jarvinen and Franssila
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1984), although whether these are distinct clinical en-
tities is not clear. Affected family members often present
with blood per rectum or anemia in the 2d decade of
life (Jass et al. 1988).Microscopically, the polyps contain
cystically dilated glands, abundant stroma, and an in-
flammatory infiltrate (Morson 1962). There have been
many reports of patients with juvenile polyposis devel-
oping gastrointestinal malignancy, including colon can-
cer (Stemper et al. 1975; Liu et al. 1978; Goodman et
al. 1979; Rozen and Baratz 1982; Jarvinen and Franssila
1984; Ramaswamy et al. 1984; Baptist and Sabatini
1985; Jones et al. 1987; Bentley et al. 1989; Scott-Con-
ner et al. 1995), stomach cancer (Stemper et al. 1975;
Yoshida et al. 1988; Scott-Conner et al. 1995), and pan-
creatic cancer (Stemper et al. 1975; Walpole and Cullity
1989). Affected family members’ risk of developing GI
malignancy has been estimated to be from 9% (Jarvinen
and Franssila 1984) to as high as 50% (Jass 1990). De-
velopment of adenocarcinoma has been hypothesized to
begin with an adenomatous focus within a juvenile
polyp, which later becomes dysplastic, and finally un-
dergoes malignant transformation (Goodman et al.
1979; Jarvinen and Franssila 1984).
FJP is a hamartomatous polyposis syndrome, as are
Peutz-Jeghers syndrome (PJS) and Cowden disease (CD).
Although the polyps in PJS are true hamartomata, some
may undergo adenomatous change, and these family
members are at increased risk for gastrointestinal ma-
lignancy. The PJS gene was mapped to chromosome 19p
by comparative genomic hybridization and linkage
(Hemminki et al. 1997; Mehenni et al. 1997), and germ-
line mutations were identified in the serine threonine
kinase gene LKB1 (Hemminki et al. 1998). In CD, af-
fected family members may develop multiple hamarto-
mata of the skin, breast, thyroid, oral mucosa, or GI
tract, and they are at risk for breast and thyroid malig-
nancies. The gene for CD was localized to chromosome
10q22-23 by linkage (Nelen et al. 1996), and germline
mutations in the PTEN gene have been found in affected
family members (Liaw et al. 1997). A third entity, termed
the “hereditary mixed-polyposis syndrome” (HMPS),
differs from these syndromes in that affected family
members have atypical juvenile polyps, colonic adeno-
mas, and colorectal carcinomas. A gene for HMPS has
been mapped to chromosome 6q by linkage (Thomas et
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al. 1996), and it remains uncertain whether HMPS is a
distinct clinical syndrome or a variant of FJP (Whitelaw
et al. 1997).
Linkage studies in FJP families have been limited, with
one report excluding APC and MCC as the genes for
FJP (Leggett et al. 1993). Other genetic studies, origi-
nally stimulated by the finding of an interstitial deletion
at 10q22-24 in an infant with multiple colonic juvenile
polyps and several congenital abnormalities (Jacoby et
al. 1997b), have focused on the region of the PTEN
gene. Evaluation for loss of heterozygosity in this region
within juvenile polyps revealed somatic deletions within
the lamina propria in 39 (83%) of 47 polyps derived
from 13 unrelated patients with FJP and 3 patients with
sporadic juvenile polyps. These findings have been in-
terpreted as evidence for a tumor-suppressor gene on
10q for FJP (termed “JP1”) (Jacoby et al. 1997a), but
a recent study of 14 FJP families found neithermutations
in PTEN nor evidence of linkage to markers on 10q22-
24 (Marsh et al. 1997). Analysis of an additional 11
cases of FJP also did not uncover mutations in the PTEN
gene (Riggins et al. 1997). Lynch et al. (1977) reported
one family thought to have both juvenile polyposis syn-
drome and CD as having a nonsense mutation in PTEN,
and Olschwang et al. (1998) described three patients
with juvenile polyposis as having PTEN mutations.
Whether these four individuals should truly be consid-
ered as having juvenile polyposis rather than CD is not
clear from these reports. The objective of the present
study was to identify by linkage analysis the chromo-
somal locus of the FJP gene in a large kindred with
generalized juvenile polyposis and gastrointestinal
cancer.
Patients and Methods
Patients
Informed consent was obtained from family members
with the approval of the Institutional Review Board at
the University of Iowa. Pathology slides and medical
records were reviewed at the University of Iowa to con-
firm the diagnosis of FJP. Individuals were considered to
be affected if they had histologic evidence of upper gas-
trointestinal or colorectal juvenile polyps. Deceased in-
dividuals with a history of gastrointestinal cancer and/
or affected offspring were also designated as affected.
Living kindred members without a definitive histologic
diagnosis of FJP were classified as having unknown af-
fection status.
Genotyping Studies
Peripheral blood was drawn and DNA extracted using
a salting-out procedure (Miller et al. 1988). Simple-tan-
dem-repeat polymorphism (STRP)markers were selected
from different candidate regions according to the rele-
vant literature, contig maps were obtained from the hu-
man physical mapping project at theWhitehead Institute
for Biomedical Research/MIT Center for Genome Re-
search (http://www-genome.wi.mit.edu), and genetic
maps were obtained from the Center for Medical Ge-
netics (http://www.marshmed.org/genetics). Primers
were obtained from Research Genetics and were am-
plified by PCR in a total volume of 10 ml. PCR reaction
conditions included 25 ng of DNA; 200 mM each of
dGTP, dATP, dTTP, and dCTP; 1 ml of 10# buffer (100
mM Tris-HCl, pH 8.3, 500 mM KCl, 15 mM MgCl2,
0.01% w/v gelatin); 2 pmol of each primer; and 0.375
U Taq DNA polymerase. Samples were incubated in a
thermocycler for 1 min at 94C, 1 min at 55C (or op-
timal annealing temperature), and 1 min at 72C, for a
total of 35 cycles. After amplification, 5 ml of stop so-
lution (95% formamide, 10 mM NaOH, 0.05% brom-
ophenol blue, 0.05% xylene cyanol) was added. Samples
were heated to 95C and were then electrophoresed
through 6% denaturing polyacrylamide gels for 2–4 h
at 60 W. Gels were silver stained (Bassam et al. 1991),
and genotypes were determined from the gels.
Linkage Analysis
Genotype data were entered into a Macintosh com-
puter using a Hypercard-based program (Nichols et al.
1993). Marker data were exported to a DOS-compatible
computer, where linkage analysis was performed using
the LODSCORE and MLINK subroutines of the FAS-
TLINK (2.3) version (Cottingham et al. 1993) of the
LINKAGE program package (Lathrop et al. 1985). Al-
though the gene frequency for FJP is not known, for this
study it was estimated to be 1/100,000. This was based
on Burt’s estimate that FJP is less common than PJS,
which is approximately one-tenth as common as familial
adenomatous polyposis (which has an incidence of 1 in
8,000) (Burt et al. 1993). Complete dominance of the
disease allele (A) was assumed, and penetrance was set
at AA  0.95, Aa  0.95, and aa  0.00. For chro-
mosome 18q markers, linkage was also calculated with
penetrance values as described for HMPS (AA  0.95,
Aa  0.95, and aa  .075) (Thomas et al. 1996). No
age-specific liability classes were used to further estimate
penetrance. Since allele frequencies could not be reliably
established in this one kindred with few spouses, initial
linkage analyses were performed using equal allele fre-
quencies. For markers from 18q, analyses were per-
formed using equal frequencies as well as those from the
CEPH database (http://www.cephgb.fr).
Mapping of DCC
The GeneBridge 4 radiation-hybrid–mapping panel
was screened (Walter et al. 1994) using primers from an
intragenic DCC dinucleotide repeat (Risinger and Boyd
1992). DCC was placed relative to STSs in the White-
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Figure 1 Pedigree of a five-generation American midwestern FJP family (the Iowa FJP kindred). Blackened symbols designate affected
family members; unblackened symbols indicate unaffected individuals or those with unknown affection status; genotyping was performed on
those marked by asterisks (*).
head Institute for Biomedical Research/MIT Center for
Genome Research radiation-hybrid map of the human
genome by means of the RHMAPPER server (http://
www-genome.wi.mit.edu/cgi-bin/contig/rhmapper.pl).
Results
FJP Kindred
The Iowa FJP kindred was the first FJP kindred de-
scribed exhibiting a wide variety of gastrointestinal car-
cinomas (Stemper et al. 1975). The updated pedigree
contains 54 living and 24 deceased members (fig. 1). A
total of 29 family members have had juvenile polyposis
and/or GI cancer, 27 with colorectal, 11 with upper GI,
and 9 with both upper- and lower-GI involvement.
Eleven individuals have had colon cancer, and 6 have
had upper gastrointestinal cancer (4 stomach, 1 duo-
denum, and 1 pancreas). Five family members have af-
fected offspring but have never been clinically screened
for polyps, 4 have had negative endoscopic or radiologic
evaluation of the colon after the age of 50 years, and
39 others either have not been screened for polyps or
have been screened prior to age 50 years. No family
members had a history of thyroid or breast carcinoma
or of pigmented macules of the buccal mucosa (Stemper
et al. 1975).
Linkage Analysis
Genotyping was performed on 43 individuals, of
whom 13 were affected (all with a histologic diagnosis
of gastrointestinal juvenile polyps), 24 were considered
to be at risk, and 6 were spouses. The linkage strategy
involved the typing of markers at loci known to play an
important role in colorectal polyposis or cancer. This
included the regions of MSH2 (2p16), MLH1 (3p21),
MCC, APC (5q21-22), HMPS (6q21), JP1, PTEN
(10q22-24), KRAS2 (12p12), TP53 (17p13), DCC
(18q21), and LKB1 (19p). Markers in the region of
CDKN2A (9q21) were also studied.
Table 1 summarizes the findings of linkage analysis
with most of these markers. There was no evidence to
suggest linkage to loci predisposing to hereditary non-
polyposis colorectal cancer (MSH2 and MLH1) or fa-
milial adenomatous polyposis (APC), or to several loci
known to play an important role in the genesis of spo-
radic colorectal cancer (MCC, KRAS2, and TP53).
There was also no evidence for linkage to loci involved
in other hamartomatous polyposis syndromes, including
HMPS, PTEN, and LKB1. Linkage of FJP to a putative
tumor-suppressor gene on 10q22-24 (JP1) was also not
suggested by these data.
In contrast, strong evidence for linkage to markers on
18q21.1 was found. The two-point maximum likelihood
data for 27 18q markers are summarized in table 2.
Seven markers had LOD scores exceeding 3.0, with a
maximum LOD (Zmax) of 5.00 atD18S1099 (v 0.001).
All of these markers have been mapped to the YAC
contig WC18.4 (http://www-genome.wi.mit.edu). Five
affected individuals had recombination events detected
with these 18q21 markers: IV-11 with D18S548; IV-7
with D18S460, D18S970, and D18S1118; III-13 with
D18S970 and D18S1118; IV-2 with D18S487,
D18S858, D18S849, and D18S1147; and II-4 with
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Table 1
Pairwise LOD Scores for FJP versus Candidate-Region STRPs
STRP
LOD SCORE AT v 
.00 .01 .05 .10 .20 .30 .40
D2S123 10.41 3.69 1.63 .81 .18 .02 .06
D2S1352 26.24 7.21 5.46 1.75 .56 .12 .03
D2S1364 9.02 1.41 .10 .31 .45 .33 .15
D3S1611 15.40 4.66 2.07 1.10 .37 .10 .00
D3S1768 4.15 1.77 .43 .02 .24 .18 .06
D5S1453 26.68 10.41 5.23 3.07 1.22 .43 .10
D5S1467 14.96 4.43 1.83 .88 .20 .03 .02
D5S346 7.48 1.53 .31 .08 .22 .12 .00
D6S1028 9.01 1.26 .08 .26 .34 .23 .10
D6S283 7.91 1.39 .38 .86 .91 .61 .26
D6S301 8.43 1.35 .17 .16 .21 .09 .01
D6S434 18.77 3.78 1.21 .34 .16 .16 .08
D6S475 18.98 6.78 3.29 1.87 .70 .24 .06
D9S259 14.28 4.55 1.96 1.00 .30 .07 .01
D9S304 14.15 4.36 2.00 1.01 .22 .03 .07
D9S319 13.91 4.46 1.53 .34 .51 .63 .41
D10S1242 17.49 6.51 3.08 1.72 .59 .17 .03
D10S1427 3.53 .45 .93 .95 .71 .42 .17
D10S219 5.44 1.55 .32 .12 .39 .35 .19
D10S1753 5.04 .72 .42 .71 .68 .42 .14
D10S573 9.77 5.29 2.49 1.36 .43 .11 .02
D12S372 9.68 3.52 1.54 .79 .22 .04 .01
D12S389 9.71 4.94 2.25 1.21 .40 .12 .03
D17S922 9.04 1.72 .53 .17 .02 .03 .01
D17S953 9.63 3.94 1.67 .76 .09 .09 .08
D17S960 9.97 2.18 .78 .28 .01 .04 .02
D17S969 9.45 2.45 .61 .03 .26 .23 .12
D19S565 24.77 9.27 4.61 2.77 1.17 .49 .20
D19S886 3.57 1.36 .16 .19 .29 .18 .05
D19S894 7.20 .82 .93 1.39 1.36 .95 .45
Table 2
Pairwise Linkage Results of FJP versus
Chromosome 18 STRPs
STRP v Zmax
D18S978 .140 .84
D18S548 .080 1.03
D18S460 .157 .37
D18S970 .500 .00
D18S1118 .152 .57
D18S473 .001 2.14
D18S470 .001 2.59
D18S1110 .001 2.47
D18S474 .001 4.24
D18S1099 .001 5.00
D18S46 .001 4.41
D18S363 .001 4.46
DCC .001 4.79
GATA06 .001 2.36
D18S1156 .001 1.37
D18S851 .016 1.60
D18S484 .025 3.31
D18S539 .013 2.10
D18S487 .111 1.22
D18S69 .065 1.42
D18S846 .001 1.46
D18S858 .048 3.20
D18S977 .001 2.69
D18S849 .105 2.58
D18S862 .229 .32
D18S1147 .174 1.51
D18S979 .420 .03
D18S862 and D18S1147. Analysis of these critical re-
combinants places the FJP gene betweenD18S1118 and
D18S487 (fig. 2), an interval of ∼11.9 cM and 34 cR
(Center for Medical Genetics, Whitehead Institute for
Biomedical Research/MIT Center for Genome Re-
search). The DCC gene was placed within this interval
by means of the GeneBridge 4 radiation-hybrid panel
(Walter et al. 1994), between WI-5257 and WI-4115.
Linkage analysis was performed under several differ-
ent assumptions, without changing the overall results.
First, clinically unaffected individuals were scored as un-
known, with a penetrance of 95% for genotype AA,
95% for Aa, and 0% for aa. Next, four individuals 150
years of age, with negative colonoscopy or barium en-
ema results, were classified as unaffected, and the same
penetrance values were used as described for HMPS (AA
 95%, Aa  95%, aa  7.5%) (Thomas et al. 1996).
LOD scores of 13.0 were found with the same seven
markers (D18S474, D18S1099, D18S46, D18S363,
DCC, D18S484, and D18S858) with both assumptions,
using the allele frequencies in the CEPH database (http:
//www.cephgb.fr), without significant differences in re-
combination fraction (v). Linkage analysis was also per-
formed using equal allele frequencies, which resulted in
LOD scores of 13.0 with 10 different markers
(D18S470, D18S1110, D18S474, D18S1099, D18S46,
D18S363, DCC, D18S484, D18S846, and D18S977).
The data reported in table 2 were derived by means of
the first method described, which appeared to use the
most conservative assumptions for linkage analysis.
Linkage analysis was also performed by classifying de-
ceased individuals with a history of GI cancer and/or
affected offspring (but without histologic confirmation
of juvenile polyposis) as having unknown affection
status, which did not change these results.
Discussion
FJP is the last of the hamartomatous polyposis syn-
dromes to be localized by genetic linkage analysis. The
focused genome screen used here identified a locus on
chromosome 18q21.1, which is at variance with the pre-
vious suggestion of a tumor-suppressor gene (JP1) for
FJP on 10q22-24 (Jacoby et al. 1997a). There was no
evidence of linkage to the 10q markers used here, which
spanned the 10q22-24 region containing the PTEN
gene. It is worth noting that identification of JP1 was
based on loss-of-heterozygosity studies and not on ge-
netic linkage. Jacoby et al. (1997a) found deletion of
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Figure 2 Schematic representation of STRPs and genes from 18q21 (left) and recombination analysis of key affected individuals (right).
STRPs are listed in their map order, based on the Center for Medical Genetics map; markers D18S977 and D18S849 lie between D18S858
and D18S862 (Whitehead Institute for Biomedical Research/MIT Center for Genome Research); and D18S46 lies betweenDPC4 andD18S363
(Hahn et al. 1996a). The locations of MADR2, SSAV1, DPC4, and DCC are representations derived from physical mapping data (Eppert et
al. 1996); the lengths of the corresponding bars shown for the map at left do not necessarily reflect the size of each gene. To the right, informative
recombination events in affected individuals that define the interval of the FJP gene are depicted as blackened boxes; unblackened boxes designate
noninformative meioses. These data suggest that the FJP gene lies between the markers D18S1118 and D18S487.
one allele ofD10S219 in 39 (83%) of 47 juvenile polyps,
and fluorescent in situ hybridization demonstrated that
10q deletions occurred within the lymphocytes and mac-
rophages of the lamina propria, but not in epithelial
cells. These results supported the theory that overgrowth
of the lamina propria is the determining event in juvenile
polyp formation (Jass 1990). Recent reports that four
individuals with juvenile polyposis had PTEN germline
mutations would appear to confirm that PTEN is the
predisposing gene on 10q22-24 in some families with
juvenile polyposis (Lynch et al. 1997; Olschwang et al.
1998). However, one of these patients was described as
having both CD and juvenile polyposis (Lynch et al.
1997), whereas the other three had no family history of
juvenile polyposis (and one of these had a thyroid nod-
ule) (Olschwang et al. 1998). These reports raise the
question whether these patients were truly affected with
juvenile polyposis or CD (Eng and Ji 1998 [in this issue]).
In 14 FJP families, Marsh et al. (1997) found no evidence
of linkage to markers on 10q22-24 or mutations in the
PTEN gene, which they concluded ruled out PTEN or
another gene in this region as the locus for FJP, at least
in a subset of these families. Similar results were found
by Riggins et al. (1997) and are in agreement with the
findings of the present study, which would rule out germ-
line mutations on 10q22-24 as the predisposing event
leading to FJP in this large family. It is likely that there
is genetic heterogeneity for the juvenile polyposis syn-
dromes, and perhaps mutations at HMPS and PTEN
represent the changes seen in some families, whereas a
locus for generalized polyposis predisposing to gastro-
intestinal carcinoma resides on 18q21.1. The findings of
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this study should help to establish FJP as a distinct entity
rather than a variant of one of the other hamartomatous
polyposis syndromes, such as PJS on 19p13 or CD on
10q23. Genetic methods will ultimately prove to bemore
useful for the classification of different families with ha-
martomatous polyposis than current methods based on
clinical phenotype.
Analysis of critical recombinants places the FJP gene
in an 11.9-cM interval between the markers D18S1118
and D18S487 (Center for Medical Genetics). Linkage
analysis revealed no recombinants with the markers
D18S473, D18S470, D18S1110,D18S474,D18S1099,
D18S46, D18S363, DCC, GATA06, D18S1156,
D18S846, or D18S977 (the latter two markers being
telomeric to the interval defined by critical recombi-
nants). The finding of genetic linkage with markers on
18q21.1 makes presymptomatic testing of at-risk indi-
viduals in this family possible. This would allow those
who have not inherited the affected parental allele to
potentially be spared from repetitive endoscopic screen-
ing for GI neoplasms, whereas those predicted to be gene
carriers would benefit from close surveillance for the
development of these tumors. Although prophylactic
surgery has been proposed (Scott-Conner et al. 1995),
this may not be necessary if periodic screening and en-
doscopic polypectomy are carried out.
One candidate gene from 18q21.1 that can be ex-
cluded from consideration as the FJP gene is MADR2,
which has been physically mapped to betweenD18S460
and D18S970 (Eppert et al. 1996), centromeric to the
recombination events seen in individuals III-13 and IV-
7. This interval on 18q21.1 does containDCC, a tumor-
suppressor gene lost in many sporadic colorectal carci-
nomas (Vogelstein et al. 1988; Fearon et al. 1990).DCC
spans ∼1.4 Mb in genomic DNA (Cho et al. 1994) and
has been shown to encode for a netrin receptor (Keino-
Masu et al. 1996). Its role in the genesis of colorectal
carcinoma is uncertain, since transgenic mice lacking a
functional DCC gene manifest not an increased rate of
intestinal tumors, but rather defects in commissural axon
projections (Fazeli et al. 1997). The latter study con-
cluded that the loss of DCC expression commonly seen
in colorectal and pancreatic cancers may be related to
changes in a linked gene. The simian sarcoma–associated
virus-1 gene (SSAV1) also lies within this interval (Eppert
et al. 1996) and contains sequences resembling retro-
virus long-terminal repeats (Brack-Werner et al. 1989).
Also mapping to this region is DPC4, a member of the
Mad gene family, involved in signal transduction of ser-
ine threonine kinase receptors (Hahn et al. 1996b). In-
terestingly, the gene for PJS has just been found to be
caused by mutations in the serine threonine kinase gene
LKB1 (Hemminki et al. 1998). DPC4 is homozygously
deleted in ∼30% of pancreatic carcinomas, and gene
mutations are seen in 22% of pancreatic tumors without
homozygous deletions (Hahn et al. 1996b). DPC4 was
also found to be lost or altered in 5 (28%) of 18 co-
lorectal carcinoma cell lines (Thiagalingam et al. 1996).
The latter study defined the minimally lost region in 55
colorectal carcinoma cell lines to span the 16-cM interval
between D18S535 and D18S858, which contains both
the DCC and DPC4 genes. This is roughly the same
interval to which the FJP gene has been mapped in this
study, except that this interval begins 4 cM telomeric to
D18S535 and ends 4 cm centromeric toD18S858 (Cen-
ter for Medical Genetics). These results suggest that the
gene responsible for FJP could be the same gene on
18q21 that is involved in the development of sporadic
colorectal or pancreatic carcinomas; whether this gene
will prove to beDCC orDPC4 awaits direct mutational
testing in FJP family members.
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